Biomarker studies typically involve collecting samples such as blood, urine, or cerebrospinal fluid from the neonate. These samples are then analyzed using techniques like mass spectrometry, ELISA (enzyme-linked immunosorbent assay), or next-generation sequencing. The goal is to identify abnormal levels of biomarkers that correlate with specific neonatal disorders.
